IDO1 and rheumatoid arthritis: Citrullinated fibrinogen (a prominent auto-antigen in RA) can affect BM-MSC function by promoting IL-6, IL-8, CCL2 expression and reducing IDO via the involvement of toll-like receptor 4 (TLR-4) and NFκB pathway (53).